RNTX
Rein Therapeutics Inc
0.744$
-3.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +270.7% | +139.3% | -42.5% | -12.7% | -38.3% | +196.7% | -54.6% | +381.7% | -34.7% | -65.1% | |
| – | +423.4% | +146.0% | -58.0% | -10.2% | -16.5% | +195.1% | -54.6% | -16.5% | -25.2% | -68.3% | |
| – | +449.8% | -42.7% | -10.4% | -50.1% | +32.7% | -48.9% | +44.3% | +233.3% | -25.7% | -75.0% | |
| – | +449.8% | +145.0% | -59.2% | -11.7% | -24.5% | +232.7% | -53.8% | -18.5% | -25.7% | -75.0% | |
| – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | -38.7% | -72.2% | |
| – | +33.5% | -96.3% | +119.0% | -2.7% | -59.9% | +9.5% | -26.1% | +2,829.1% | -85.0% | -51.2% | |
| – | +59.7% | +20.1% | +9.8% | +8.7% | -32.2% | +13.8% | -24.9% | +29.6% | +31.1% | +7.5% | |
| – | – | – | – | – | -62.3% | -44.6% | -64.5% | +45.5% | – | – | |
| – | +207.5% | -18.8% | +8.2% | -16.1% | +9.9% | -24.2% | +42.1% | -30.8% | -23.4% | +336.4% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -59.0% | -18.1% | -24.2% | +261.0% | -57.6% | -63.0% | +689.8% | -68.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -74.5% | +2.2% | +1.3% | +290.1% | +41.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.